PATENT CLAIM ANALYSIS

Application Number: 15986485
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "326000"]

Abstract:
The disclosure relates to compounds and methods of treatment relating to nicotinic receptor antagonists. For example, the compounds and methods of treatment function block the activity of certain acetylcholine receptors and subtypes therein, and are useful treating diseases and conditions mediated by nicotinic receptor stimulation, e.g., diabetes mellitus, chronic kidney disease, acute kidney failure, and reduction of blood glucose levels.

Claim (Index 8):
A method of  claim 1 , wherein said disease or disorder is nicotine-exacerbated chronic kidney disease.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 93.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14127699', '14742570', '13014947', '14128378', '09812269']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.775312462375974
- 35 USC 102 Novelty (BERT): 0.5445299614060116
- Combined Prediction Score: 0.7522342122789778
- Mean Citation Score: 343.1448759999999
- Max Citation Score: 379.546
- Similarity Product: 235.456588175416

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test